Wikidata

(Q51338027)

English

Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes.

scientific article published on 4 July 2013

In more languages

Statements

title
Eight weeks of treatment with long-acting GLP-1 analog taspoglutide improves postprandial insulin secretion and sensitivity in metformin-treated patients with type 2 diabetes. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
23831441
retrieved
3 April 2018
reference URL
http://europepmc.org/abstract/MED/23831441

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q51338027&oldid=1901602225"